Mercer Global Advisors Inc. ADV Sells 5,593 Shares of Sanofi (NASDAQ:SNY)

Mercer Global Advisors Inc. ADV lowered its holdings in Sanofi (NASDAQ:SNY) by 4.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 110,233 shares of the company’s stock after selling 5,593 shares during the period. Mercer Global Advisors Inc. ADV’s holdings in Sanofi were worth $5,348,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. POM Investment Strategies LLC bought a new position in Sanofi in the 2nd quarter worth about $25,000. Register Financial Advisors LLC bought a new position in shares of Sanofi in the first quarter valued at approximately $29,000. Larson Financial Group LLC grew its stake in Sanofi by 480.8% during the first quarter. Larson Financial Group LLC now owns 604 shares of the company’s stock valued at $29,000 after acquiring an additional 500 shares in the last quarter. Johnson Financial Group Inc. bought a new stake in Sanofi during the 4th quarter worth approximately $31,000. Finally, Palisade Asset Management LLC purchased a new stake in Sanofi in the 1st quarter worth approximately $31,000. 10.04% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on SNY. Citigroup upgraded shares of Sanofi to a “strong-buy” rating in a research report on Tuesday, September 17th. StockNews.com upgraded Sanofi from a “buy” rating to a “strong-buy” rating in a research report on Friday. Finally, Argus raised their price target on Sanofi from $55.00 to $60.00 and gave the company a “buy” rating in a report on Friday, July 26th. Three equities research analysts have rated the stock with a hold rating, one has issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $57.50.

Sanofi Trading Down 1.1 %

NASDAQ SNY opened at $57.63 on Friday. The stock’s 50-day simple moving average is $54.34 and its two-hundred day simple moving average is $50.48. Sanofi has a twelve month low of $42.63 and a twelve month high of $58.97. The company has a quick ratio of 0.65, a current ratio of 1.00 and a debt-to-equity ratio of 0.17. The company has a market capitalization of $145.96 billion, a price-to-earnings ratio of 28.96, a PEG ratio of 1.62 and a beta of 0.60.

Sanofi (NASDAQ:SNY) last issued its earnings results on Thursday, July 25th. The company reported $0.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.88 by $0.05. The business had revenue of $10.75 billion during the quarter, compared to analyst estimates of $16.86 billion. Sanofi had a return on equity of 26.29% and a net margin of 9.60%. Sanofi’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.95 earnings per share. Research analysts forecast that Sanofi will post 4.25 EPS for the current fiscal year.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.